Microsoft’s diversification strategy includes utilizing some of its resources to help improve the diagnosis of cancer to find cures for certain cancers. The research is based at Microsoft’s ‘biological computation’ labs in Cambridge, U.K.
As Digital Journal has recently reported Microsoft has recently launched Healthcare NeXT, which is a cloud-based, artificial intelligence and research project with the aim of fostering digital tools to encourage people to lead healthier lives as well as offering analytics to support healthcare research.
Microsoft’s biological computation laboratories approach is similar to the approach taken by IBM with its Watson system, according to PharmaPhorum. This involves applying machine learning and artificial intelligence capabilities to analyze complex biological data. These Industry 4.0 solutions represent a new and potentially successful input into healthcare research.
Part of the research that Microsoft is undertaking is into cancer. This fits with a different approach that the …